Gene · 79188
Papers1,602
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,602
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic value and immunological role of cathepsin S gene in pan‑cancer. | Oncol Lett | 2024 | 38108072 | PubTator, text mining | PubMed |
| [Management of cardiomyopathies : New ESC guidelines 2023]. | Herz | 2024 | 38051386 | PubTator, text mining | PubMed |
| Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer. | Nucleic Acids Res | 2024 | 38015476 | PubTator, text mining | PubMed |
| HSF1 Inhibits Antitumor Immune Activity in Breast Cancer by Suppressing CCL5 to Block CD8+ T-cell Recruitment. | Cancer Res | 2024 | 37890164 | PubTator, text mining | PubMed |
| Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study. | Breast Cancer Res Treat | 2024 | 37773555 | PubTator, text mining | PubMed |
| Assessment of Apparent Diffusion Coefficient Parameters and Coefficient of Variance in Discrimination of Receptor Status and Molecular Subtypes of Breast Cancer. | Curr Med Imaging | 2024 | 37691204 | PubTator, text mining | PubMed |
| Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer. | J Natl Cancer Inst | 2024 | 37676829 | PubTator, text mining | PubMed |
| CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer. | Biomol Biomed | 2024 | 37597212 | PubTator, text mining | PubMed |
| HTRA1 expression is associated with immune-cell infiltration and survival in breast cancer. | Transl Cancer Res | 2023 | 38197075 | PubTator, text mining | PubMed |
| Cardiac MRI and Clinical Outcomes in TMEM43 Arrhythmogenic Cardiomyopathy. | Radiol Cardiothorac Imaging | 2023 | 38166344 | PubTator, text mining | PubMed |
| Photoluminescent copper(I) iodide alkylpyridine thin films as sensors for volatile halogenated compounds. | Front Chem | 2023 | 38146426 | PubTator, text mining | PubMed |
| Cardiac Magnetic Resonance as Risk Stratification Tool in Non-Ischemic Dilated Cardiomyopathy Referred for Implantable Cardioverter Defibrillator Therapy-State of Art and Perspectives. | J Clin Med | 2023 | 38137821 | PubTator, text mining | PubMed |
| Gene Signature Associated with Nervous System in an Experimental Radiation- and Estrogen-Induced Breast Cancer Model. | Biomedicines | 2023 | 38137332 | PubTator, text mining | PubMed |
| Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting. | PLoS One | 2023 | 38117806 | PubTator, text mining | PubMed |
| Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial. | Cell Rep Med | 2023 | 38086377 | PubTator, text mining | PubMed |
| Integration of genomics and transcriptomics highlights the crucial role of chromosome 5 open reading frame 34 in various human malignancies. | Aging (Albany NY) | 2023 | 38078888 | PubTator, text mining | PubMed |
| miR-877-5p as a Potential Link between Triple-Negative Breast Cancer Development and Metabolic Syndrome. | Int J Mol Sci | 2023 | 38069080 | PubTator, text mining | PubMed |
| Advancing breast cancer subtyping: optimizing immunohistochemical staining classification with insights from real-world Taiwanese data. | Am J Cancer Res | 2023 | 38058819 | PubTator, text mining | PubMed |
| Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. | Genome Med | 2023 | 38053165 | PubTator, text mining | PubMed |
| PAIRWISE NONLINEAR DEPENDENCE ANALYSIS OF GENOMIC DATA. | Ann Appl Stat | 2023 | 38046186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79188/papers?page=5